MICHAEL A VALENTINO
Medical Practice in Philadelphia, PA
License number
Pennsylvania MD452361
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Philadelphia, PA 19106
Personal information
See more information about MICHAEL A VALENTINO at radaris.comName
Address
Phone
448 Barker Dr, West Chester, PA 19380
629 Waterfall Way, Phoenixville, PA 19460
800 Avondale Rd, Wallingford, PA 19086
1114 Yardley Commons, Morrisville, PA 19067
Organization information
See more information about MICHAEL A VALENTINO at bizstanding.comMichael Valentino
2836 Edgemont St, Philadelphia, PA 19134
Phone:
(215) 739-2864 (Phone)
Email:
SIC:
7389 - Business Services, Not Elsewhere Classified
Michael Valentino, LLC
3307 Meridian St, Philadelphia, PA 19136
Industry:
Single-Family House Construction
Professional information
Dr. Michael A Valentino, Philadelphia PA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
JEFFERSON UNIVERSITY PHYSICIAN UROLOGY DEPARTMENT
833 Chestnut St SUITE 701, Philadelphia 19107
(215) 955-7534 (Phone), (215) 955-6410 (Fax)
833 Chestnut St SUITE 701, Philadelphia 19107
(215) 955-7534 (Phone), (215) 955-6410 (Fax)
Languages:
English
Education:
Medical School
Thomas Jefferson University
Graduated: 2012
Thomas Jefferson University
Graduated: 2012
Use Of Guanylyl Cyclase C Agonists To Suppress Appetite
US Patent:
2012006, Mar 15, 2012
Filed:
Feb 24, 2010
Appl. No.:
13/203041
Inventors:
Michael Valentino - Philadelphia PA, US
Scott A. Waldman - Ardmore PA, US
Scott A. Waldman - Ardmore PA, US
Assignee:
THOMAS JEFFERSON UNIVERSITY - Philadelphia PA
International Classification:
A61K 38/17, A61P 3/00, A61P 1/12, A61K 35/74
US Classification:
424 934, 514 49
Abstract:
Compositions comprising a guanylyl cyclase C agonist formulated for sustained specific release of an amount effective to suppress appetite when administered orally to an individual are disclosed. Compositions comprising a guanylyl cyclase C agonist formulated for intravenous delivery in an amount effective to suppress appetite when administered intravenously to an individual are also disclosed. Methods of suppressing appetite in an individual are disclosed.